Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
Emisphere Technologies Press Releases

Emisphere Signs License Agreement with Novo Nordisk to Develop Oral Formulations of Four Molecules Targeting Metabolic Indications

23 October 2015

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Follow this company to receive notifications when they update


Go Top